Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cellvax logo — Cellvax, founded in 2001, is a preclinical biotech company w...

Cellvax

Cellvax, founded in 2001, is a preclinical biotech company which provides in vitro and in vivo studies allowing accelera

Founded 2001 France France 7 employees Non Equity Assistance Biotechnology, Health Care

General Information

Company Name Cellvax
Founded Year 2001
Location France France
Employees 7
Industries Biotechnology, Health Care
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with Cellvax. To contact Cellvax, visit cellvax-pharma.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cellvax compare?

A PDF of Cellvax and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cellvax soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cellvax

Cellvax is a preclinical biotech company founded in 2001, specializing in innovating drug validation studies in vitro and in vivo for unmet medical needs, particularly in the fields of cancer and osteoarthritis (OA). Based in France, the company has experienced rapid growth, employing motivated and skilled scientists and engineers who work collaboratively on various innovative products.

Through its comprehensive in vitro and in vivo studies, Cellvax aims to accelerate the drug development process. The company has received non-equity assistance investment from Eurasante as of 01 January 2001, further bolstering its potential to make significant advancements in the biotechnology and healthcare industries.

Business keywords: Preclinical studies CRO, Drug validation, In vitro studies, In vivo studies, Cancer research, Osteoarthritis research, Biomarkers, Animal models, PK/Bio-distribution, Toxicology studies, In vivo imaging, Histology, Syngeneic tumor models, Subcutaneous & Orthotopic cancer models, Technology-driven preclinical service

Services & Products

in vitro and in vivo studies
toxicity and PK/Biodistribution studies
large animal model support
GLP toxicology studies
clinical trials support

Target Customers

biotech companies pharmaceutical companies public laboratories

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
Eurasante
01 Jan 2001

Cellvax Alternatives & Competitors

Cellvax vs
XenTech
XenTech France

Premium quality preclinical oncology CRO, pioneering the PDX technology for more than 16 years.

Seed
36 employees
Biotechnology, Health Care

FAQ About Cellvax

Cellvax, founded in 2001, is a preclinical biotech company which provides in vitro and in vivo studies allowing accelera
Cellvax was founded in 2001.
Cellvax is headquartered in France.
Cellvax operates in Biotechnology and Health Care. Its work centres on Preclinical studies CRO, Drug validation, In vitro studies and In vivo studies. Its customers include biotech companies, pharmaceutical companies and public laboratories.
Cellvax has approximately 7 employees.
Cellvax has completed 1 funding round. The latest funding stage is Non Equity Assistance.
Cellvax offers: in vitro and in vivo studies, toxicity and PK/Biodistribution studies, large animal model support, GLP toxicology studies, clinical trials support.
Top alternatives and competitors to Cellvax include XenTech. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cellvax and XenTech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cellvax, https://bouncewatch.com/company/cellvax, updated 7 June 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout